Mometasona Furoato Vir (Mometasone Furoate)

Mometasone furoate binds to glucocorticoid receptors in the cells lining the nasal mucosa. This binding modifies gene expression, decreasing production of inflammatory cytokines and chemokines, which reduces swelling, mucus production and immune cell infiltration in the nose.

The prescribed dose of Mometasona Furoato Vir is determined by the treating physician based on the patient’s age, severity of symptoms and clinical response. Patients should follow the prescriber’s instructions and not alter the dosing regimen on their own.

Safety data for mometasone furoate nasal spray in pregnancy and lactation are limited. Healthcare providers usually weigh potential benefits against possible risks. Women who are pregnant, planning pregnancy, or breastfeeding should discuss use with their doctor before starting treatment.

To order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Mometasone furoate is a high‑potency, once‑daily nasal corticosteroid with a favorable safety profile when used at recommended doses. Compared with older agents such as beclomethasone, it often provides comparable or superior symptom control with lower systemic absorption, reducing the risk of systemic side effects.

Store the nasal spray at room temperature, below 25 °C (77 °F). Keep it in the original packaging, protect it from moisture and direct sunlight, and ensure the cap is tightly closed when not in use to maintain product integrity.

Mometasona Furoato Vir is a nasal spray. The patient should gently blow the nose, tilt the head slightly forward, insert the nozzle into one nostril, and spray the prescribed number of sprays while breathing in gently. The process is repeated in the other nostril if directed by the prescriber.

Serious risks, though rare, include nasal septal perforation, severe allergic reactions such as anaphylaxis, adrenal suppression with prolonged high‑dose use, and opportunistic fungal infections of the nasal cavity. Patients should seek immediate medical attention if they notice unusual bleeding, persistent pain, or signs of systemic corticosteroid effects.

Individuals with known hypersensitivity to mometasone furoate or any component of the formulation should avoid the product. It is also contraindicated in patients with untreated fungal infections of the nose and should be used with caution in those who have recently undergone nasal surgery or have a history of septal perforation.